IP Library Granted Patent US 8,895,086
Granted Patent B2
US 8,895,086 · App. 14/033,713 · Granted Nov 25, 2014

Enteric coated multiparticulate composition with proteinaceous subcoat

Inventors: Syed Shah (Boca Raton, FL); Fred Hassan (Boca Raton, FL)
Assignee: Zx Pharma, LLC
A61K9/5073A61K36/534A61K9/5089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,086
App. No.
14/033,713
Granted
Nov 25, 2014
Kind
B2
Abstract

A multiparticulate composition includes a plurality of individual enteric coated cores containing one or more terpene-based active ingredients and having a continuous proteinaceous subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings. The continuous proteinaceous subcoating layer prevents volatile terpene-based active ingredients from leaving the core, even when the core is heated during processing or stored for long periods above room temperature. The multiparticulate composition may be used to treat gastrointestinal disorders.

Claims (13)

1. A multiparticulate composition comprising a plurality of individual spheroidal enteric coated cores having a diameter of about 0.1 mm to about 3 mm, said individual spheroidal enteric coated cores containing one or more terpene-based active ingredients and having a continuous gelatin film subcoating layer covering the individual cores and separating the individual cores from their respective enteric coatings, wherein the cores comprise about 10% w/w to about 35% w/w of the one or more terpene-based active ingredients, about 40% w/w to about 75% w/w microcrystalline cellulose, and about 2% w/w to about 10% w/w methyl cellulose, and about 0.05% w/w to about 20% w/w of croscarmellose sodium; the subcoating comprises about 3.5% w/w to about 25% w/w of the enteric coated cores; and the enteric coating comprises about 2% to about 35% w/w of the enteric coated cores.

2. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise a proton pump inhibitor.

3. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise an anti-inflammatory.

4. The multiparticulate composition of claim 1 , wherein the enteric coated cores further comprise an immune suppressor.

5. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include terpene-containing essential oils and/or L-menthol.

6. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include peppermint oil and/or L-menthol.

7. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol and caraway oil.

8. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol and peppermint oil.

9. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include peppermint oil and caraway oil.

10. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol and green tea extract containing epigallocatechin gallate.

11. The multiparticulate composition of claim 1 , wherein the one or more terpene-based active ingredients include L-menthol from an at least 80% pure L-menthol source dissolved in an essential oil.

12. The multiparticulate composition of claim 1 , wherein the continuous gelatin film subcoating layer covering the core is adapted to prevent the one or more terpene-based active ingredients from mixing with the enteric coating.

13. The multiparticulate composition of claim 1 , wherein the enteric coating has a glass transition temperature higher than a standard boiling point or sublimation point of the one or more terpene-based active ingredients.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2020
From: ZX PHARMA, LLC
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054516/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2013
From: SHAH, SYED M.; HASSAN, FRED
To: ZX PHARMA, LLC
Reel/Frame 031273/0430 →
Continuity (3)
Provisional Application 61815073 · Apr 23, 2013
Provisional Application 61880294 · Sep 20, 2013
Related Publication 20140314860A1 · Oct 23, 2014